Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases

JAMA
April 10, 2018, Vol 319, No. 14, Pages 1415-1520
http://jama.jamanetwork.com/issue.aspx

Viewpoint
Novel Vaccine Technologies: Essential Components of an Adequate Response to Emerging Viral Diseases
Barney S. Graham, MD, PhD; John R. Mascola, MD; Anthony S. Fauci, MD
JAMA. 2018;319(14):1431-1432. doi:10.1001/jama.2018.0345
In this Viewpoint, Anthony Fauci and colleagues review modern technological advances that facilitate acceleration of vaccine development in response to new and emerging viral disease threats, and argue for investment in surveillance in developing countries to expedite pathogen identification and jump-start the vaccine development process.